Glycated hemoglobin (HbA1c) levels are widely regarded as a marker of medium-term blood glucose control and are extensively applied clinically as an indicator of a person's average or integrated glycemic control over the preceding 2-3 months.
Since the year 2000, an estimate or simulation of HbA1c levels has been incorporated within the AIDA program [REF].